Gulana Agayeva

Department of Cardiology, Zeferan Hospital, Baku, Azerbaijan

Publications

  • Review Article   

    Author(s): Gulana Agayeva76772* and Narmin Islamova76773

    Cardiac amyloidosis is a rare and often underdiagnosed infiltrative cardiomyopathy characterized by the deposition of misfolded proteins, known as amyloids, within the heart tissue. Symptoms of cardiac amyloidosis often mimic other forms of heart failure and include restrictive cardiomyopathy, arrhythmias and diastolic dysfunction. Diagnosis relies on a combination of echocardiography, cardiac Magnetic Resonance Imaging (MRI), nuclear imaging and tissue biopsy, with the latter being the gold standard. Treatment strategies vary depending on the type of amyloidosis, ranging from chemotherapy and stem cell transplantation in Amyloid Light-chain (AL) to liver transplantation and novel pharmacologic agents in Hereditary Transthyretin-related Amyloidosis (ATTR). Despite advancements in treatment, the prognosis remains variable and early diagnosis is critical for improvin.. Read More»
    DOI: 10.31858/0975-8453.15.12.369-372

    Abstract HTML PDF